Development of optimized vectors for gene therapy
Open Access
- 19 January 1999
- journal article
- editorial
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 96 (2) , 324-326
- https://doi.org/10.1073/pnas.96.2.324
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicityNature Genetics, 1998
- Long-Term Erythropoietin Expression in Rodents and Non-Human Primates Following Intramuscular Injection of a Replication-Defective Adenoviral VectorHuman Gene Therapy, 1997
- Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo.Journal of Clinical Investigation, 1997
- Ligand-inducible and liver-specific target gene expression in transgenic miceNature Biotechnology, 1997
- In Vivo Expression of Full-Length Human Dystrophin from Adenoviral Vectors Deleted of All Viral GenesHuman Gene Therapy, 1996
- Dimeric ligands define a role for transcriptional activation domains in reinitiationNature, 1996
- Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectorsNature Medicine, 1996
- Ecdysone-inducible gene expression in mammalian cells and transgenic mice.Proceedings of the National Academy of Sciences, 1996
- Transcriptional Activation by Tetracyclines in Mammalian CellsScience, 1995
- A 5′ element of the chicken β-globin domain serves as an insulator in human erythroid cells and protects against position effect in DrosophilaCell, 1993